Strongbridge Biopharma (SBBP) Prices 11.11M Share Common Offering at $2.25/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- Comstock Resources signs $1.65B deal with SOCAR, $450M JV
After-Hours Movers 9/16: (MLHR) (SCS) (MRNA) Higher; (SBBP) (NCNA) (FSLR) Lower (more...)
September 16, 2020 5:35 PM EDTAfter-Hours Movers
Herman Miller (NASDAQ: MLHR) 15.2% HIGHER; reported Q1 EPS of $1.24, $0.98 better than the analyst estimate of $0.26. Revenue for the quarter came in at $626.8 million versus the consensus estimate of $524.83 million.
Strongbridge Biopharma (SBBP) Announces Proposed Public Offering of Ordinary Shares
September 16, 2020 4:36 PM EDTStrongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that it intends to offer and sell ordinary shares in an underwritten public offering. The Company also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of... More
